Physician
Edwin F. Aguilar, M.D., P.C.
Edwin F. Aguilar, M.D., P.C. was paid $5.58M by Medicaid between Jan 2018 and Nov 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoEDWIN F. AGUILAR, M.D., P.C.
BALTIMORE, MD 21237
BALTIMORE, MD 21237
33aNPI1124313499assigned 06/15/2011
33bProvider typePediatrics Physician
28Total paid$5.58M
24GClaims117,094
24DCodes billed61
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#17 of 306
Median peer was paid$206K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,308 | $27K | |
| 2019 | 1,015 | $17K | |
| 2020 | 22,565 | $843K | |
| 2021 | 23,656 | $1.08M | |
| 2022 | 27,960 | $1.38M | |
| 2023 | 18,116 | $1.04M | |
| 2024incomplete | 22,474 | $1.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 25,730 | 21,418 | $2.20M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 8,793 | 7,728 | $1.03M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.0% | 3,776 | 3,573 | $393K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 3,272 | 3,083 | $342K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.6% | 3,248 | 2,932 | $312K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.3% | 1,792 | 1,648 | $238K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 1,504 | 1,403 | $175K |
| D1206 | Topical application of fluoride varnish | 1.9% | 4,573 | 4,194 | $106K |
| 92552 | 1.7% | 3,899 | 3,624 | $96K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 4,909 | 4,579 | $67K |
| 90686 | 1.1% | 2,976 | 2,795 | $62K | |
| 90698 | <1% | 2,272 | 2,109 | $49K |
49 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 312 | $46K |
| 90670 | <1% | 1,789 | $38K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,793 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 764 | $36K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,897 | $35K |
| 92551 | <1% | 3,573 | $32K | |
| 90677 | <1% | 478 | $27K | |
| 94760 | <1% | 12,792 | $24K | |
| 96127 | <1% | 2,839 | $24K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,097 | $23K |
| 90680 | <1% | 1,072 | $23K | |
| 99177 | <1% | 3,872 | $18K | |
| 99381 | <1% | 158 | $17K | |
| 90633 | <1% | 701 | $15K | |
| 90744 | <1% | 631 | $14K | |
| 90710 | <1% | 500 | $11K | |
| 99173 | <1% | 3,872 | $9K | |
| 99050 | <1% | 1,005 | $9K | |
| 99401 | <1% | 298 | $8K | |
| 99051 | <1% | 2,208 | $8K | |
| 90651 | <1% | 329 | $7K | |
| 87807 | <1% | 640 | $6K | |
| 0071A | <1% | 125 | $5K | |
| 90656 | <1% | 187 | $4K | |
| 90661 | <1% | 136 | $4K | |
| 90734 | <1% | 159 | $4K | |
| 90696 | <1% | 140 | $3K | |
| 90619 | <1% | 99 | $3K | |
| 90715 | <1% | 126 | $3K | |
| 0072A | <1% | 61 | $2K | |
| 90620 | <1% | 97 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 339 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $2K |
| 96160 | <1% | 537 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 81 | $760.00 |
| 0001A | <1% | 14 | $520.00 | |
| 91307 | <1% | 243 | $517.58 | |
| 96161 | <1% | 155 | $428.01 | |
| 3008F | <1% | 1,013 | $390.00 | |
| 90716 | <1% | 14 | $325.92 | |
| 90688 | <1% | 16 | $325.92 | |
| W7000 | <1% | 65 | $262.24 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $142.52 |
| 81002 | <1% | 48 | $98.17 | |
| 99000 | <1% | 743 | $68.84 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 16 | $1.50 |
| 91300 | 0% | 15 | $0.00 | |
| 36416 | 0% | 1,258 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGUILAR LOPEZ, EDWIN (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Riverdale Park Pediatrics PC | Glen Burnie, MD | $121K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.